Girdhar Anurag, Ewer Andrew K
Department of Neonatology, Birmingham Women's Hospital NHS Trust, Birmingham, United Kingdom.
Institute of Metabolism and Systems Research, College of Medical and Dental Sciences, University of Birmingham, Birmingham, United Kingdom.
Crit Care Nurs Clin North Am. 2024 Mar;36(1):99-110. doi: 10.1016/j.cnc.2023.09.001. Epub 2023 Oct 17.
Pulse oximetry screening (POS) was first described over 20 years ago. However, in recent years, major clinical trials have demonstrated consistent test accuracy for the detection of critical congenital heart defects (CCHD). International uptake of POS has progressed well over the last 10 years with most major high-income countries now recommending screening. This review describes the evidence base which has led to this, the current debate regarding choice of screening algorithm, and the future areas for further research.
脉搏血氧饱和度筛查（POS）在20多年前首次被描述。然而，近年来，主要临床试验已证明其在检测严重先天性心脏病（CCHD）方面具有一致的检测准确性。在过去10年里，POS在国际上的应用进展顺利，大多数主要高收入国家现在都建议进行筛查。这篇综述描述了促成这一情况的证据基础、当前关于筛查算法选择的争论以及未来需要进一步研究的领域。
